iCUREX
Kagoshima medical-device company developing chitosan hydrogel materials for wound care, including the syringe-delivered Kitosla CX dressing.
¥140MSeries A first close: equity and debt
ParticipantActivity from announced rounds
Kagoshima medical-device company developing chitosan hydrogel materials for wound care, including the syringe-delivered Kitosla CX dressing.
A professional communication platform connecting healthcare workers and medical students with their communities and employers.